Clinical Trial: Randomized, DoubleBlind, PlaceboControlled, DoseEscalating Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of HEC648 Injection Following Single and Multiple Doses in Healthy Study Participants (China)

China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Randomized, DoubleBlind, PlaceboControlled, DoseEscalating Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of HEC648 Injection Following Single and Multiple Doses in Healthy Study Participants'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133083

Registration Time: 2026/09/21

Type: Interventional study

Primary Sponsor: Peking University First Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342994

Published by HT Digital Content Services with permission from Health Daily Digest....